hepatitis

7 Must-Read Stories In June 2017

Climate change, solar energy and disease were key issues in the month of June.

7 Must-Read Stories In May 2017

Sleep was a big concern in May, but new drugs and artificial intelligence look set to make it better.

The State Of Infectious Disease Control In Post-SARS China

China has improved its infection control measures in the aftermath of SARS, but common diseases still pose a problem.

Cipla Launches Hepatitis B Vaccine In India

Cipla's hepatitis B vaccine can prevent 95 percent of the recipients from developing a chronic infection, protecting them for decades.

TaiGen, HEC ChangJiang To Jointly Develop Chronic Hep C Treatments

The new company will develop, manufacture and commercialize treatments for chronic Hepatitis C virus infection in the Greater China region.

Liver Fibrosis-Fighting Hormones Found

Insulin-like growth factor-I has been shown to reduce fatty deposits, inflammation and fibrosis in mice with symptoms of non-alcoholic liver disease.

Combination HepC Treatment Tested In Malaysia, Thailand

The Drugs for Neglected Diseases initiative has launched a clinical trial of a hepatitis C combination drug treatment which costs less than US$300.

Cipla Launches Hepcvir-L For HepC Genotype 1 Patients

Hepcvir-L will be provided to patients in India at the fraction of the cost of branded Ledipasvir-Sofosbuvir under a licensing agreement with Gilead Sciences Inc.

Hepatitis C Tied To Parkinson’s Risk, Says Study

A nation-wide study in Taiwan has revealed a link between infection with hepatitis C and the development of Parkinson's disease.

How Hepatitis C Escapes Our Immune System

The hepatitis C NS3 protein plays an important role in subverting the host immune response to establish a chronic infection, scientists say.